Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when UNCY files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsUnicycive director Gaurav Aggarwal resigns from Board, no disagreement cited
Filed April 6, 2026 · Period ending April 6, 2026 · ~1 min read
Key Changes
-
medium
Director Gaurav Aggarwal resigned from the Board effective April 6, 2026. The company stated the resignation was not due to any disagreement with management or the Board on operations, policies, or practices.
Item 5.02 verify on EDGAR →
Summary
Unicycive Therapeutics disclosed that director Gaurav Aggarwal resigned from its Board of Directors on April 6, 2026. The company explicitly stated that Dr. Aggarwal's departure was not the result of any disagreement with management or the Board regarding the company's operations, policies, or practices—language typically included to signal an amicable separation.
For retail investors, director resignations can sometimes indicate internal concerns, but the explicit "no disagreement" language here suggests a routine departure. The company thanked Dr. Aggarwal for his service. Investors should watch for any follow-up disclosure about a replacement director or changes to Board committee composition, as well as whether the company provides additional context in its next proxy filing about the circumstances of the resignation.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 8, 2026 · How we verify